相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aging and Alzheimer's disease pathology
Renpei Sengoku
NEUROPATHOLOGY (2020)
Trends in life expectancy: did the gap between the healthy and the ill widen or close?
Anna C. Meyer et al.
BMC MEDICINE (2020)
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease
Sahil Khan et al.
CURRENT NEUROPHARMACOLOGY (2020)
Biochemical Markers in Alzheimer's Disease
Alessandro Rabbito et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval
Martin Tolar et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
The Alzheimer Precision Medicine Initiative
Harald Hampel et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Understanding the Amyloid Hypothesis in Alzheimer's Disease
Giulia Paroni et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
On the Etiopathogenesis and Pathophysiology of Alzheimer's Disease: A Comprehensive Theoretical Review
Tobore Onojighofia Tobore
JOURNAL OF ALZHEIMERS DISEASE (2019)
In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer's disease
Hanseul Park et al.
NATURE NEUROSCIENCE (2019)
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
Lisa Vermunt et al.
ALZHEIMERS & DEMENTIA (2019)
Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid
Ting Yang et al.
ANNALS OF NEUROLOGY (2019)
Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial
Adam L. Boxer et al.
LANCET NEUROLOGY (2019)
The viral protein corona directs viral pathogenesis and amyloid aggregation
Kariem Ezzat et al.
NATURE COMMUNICATIONS (2019)
Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options
Jeffrey L. Cummings et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Biomarker definitions and their applications
Robert M. Califf
EXPERIMENTAL BIOLOGY AND MEDICINE (2018)
Precision Medicine
Alan R. Weil
HEALTH AFFAIRS (2018)
Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls
Einar M. Sigurdsson
JOURNAL OF ALZHEIMERS DISEASE (2018)
Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus alpha-synuclein and beta-amyloid aggregates
Barbara E. Stopschinski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease
Paul J. Cheng-Hathaway et al.
MOLECULAR NEURODEGENERATION (2018)
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE REVIEWS NEUROLOGY (2018)
Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease A Randomized Clinical Trial
Michael S. Rafii et al.
JAMA NEUROLOGY (2018)
STIM1 deficiency is linked to Alzheimer's disease and triggers cell death in SH-SY5Y cells by upregulation of L-type voltage-operated Ca2+ entry
Carlos Pascual-Caro et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
Xianyuan Xiang et al.
MOLECULAR NEURODEGENERATION (2018)
Disruption of the psychiatric risk gene Ankyrin 3 enhances microtubule dynamics through GSK3/CRMP2 signaling
Jacob C. Garza et al.
TRANSLATIONAL PSYCHIATRY (2018)
Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons
Jacqueline P. Robbins et al.
FRONTIERS IN NEUROSCIENCE (2018)
The antimicrobial protection hypothesis of Alzheimer's disease
Robert D. Moir et al.
ALZHEIMERS & DEMENTIA (2018)
Altered γ-Secretase Processing of APP Disrupts Lysosome and Autophagosome Function in Monogenic Alzheimer's Disease
Christy O. Y. Hung et al.
CELL REPORTS (2018)
Genomic variants, genes, and pathways of Alzheimer's disease: An overview
Adam C. Naj et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2017)
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization
Piotr Lewczuk et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease
Yu Yamazaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
CRISPR Transcriptional Activation Analysis Unmasks an Occult γ-Secretase Processivity Defect in Familial Alzheimer's Disease Skin Fibroblasts
Keiichi Inoue et al.
CELL REPORTS (2017)
Antibody Therapeutics Targeting Aβ and Tau
Gilbert Gallardo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer's PSEN2N141I neurons
Maitane Ortiz-Virumbrales et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
An Aβ3-10-KLH vaccine reduced Alzheimer's disease-like pathology and had a sustained effect in Tg-APPswe/PSEN1dE9 mice
Yuan Meng et al.
BRAIN RESEARCH (2017)
Implicating Receptor Activator of NF-κB (RANK)/RANK Ligand Signalling in Microglial Responses to Toll-Like Receptor Stimuli
Anton Kichev et al.
DEVELOPMENTAL NEUROSCIENCE (2017)
ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion
Yu-Wen Alvin Huang et al.
CELL (2017)
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
Eric R. Siemers et al.
ALZHEIMERS & DEMENTIA (2016)
Extracellular Tau Paired Helical Filaments Differentially Affect Tau Pathogenic Mechanisms in Mitotic and Post-Mitotic Cells: Implications for Mechanisms of Tau Propagation in the Brain
Merina Varghese et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer's disease model
Loukia Katsouri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The case for rejecting the amyloid cascade hypothesis
Karl Herrup
NATURE NEUROSCIENCE (2015)
Herpes virus in Alzheimer's disease: relation to progression of the disease
Ilaria Carbone et al.
NEUROBIOLOGY OF AGING (2014)
Dopaminergic Modulation of Cortical Plasticity in Alzheimer's Disease Patients
Giacomo Koch et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
Susanne Ostrowitzki et al.
ARCHIVES OF NEUROLOGY (2012)
APP dimer formation is initiated in the endoplasmic reticulum and differs between APP isoforms
Simone Isbert et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Robert Howard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study
P. Lewczuk et al.
MOLECULAR PSYCHIATRY (2010)
Stem cells for the treatment of neurodegenerative diseases
Elise Dantuma et al.
STEM CELL RESEARCH & THERAPY (2010)
Adult neural stem cells in the mammalian central nervous system
Dengke K. Ma et al.
CELL RESEARCH (2009)
Involvement of ROS in BBB dysfunction
Pamela B. L. Pun et al.
FREE RADICAL RESEARCH (2009)
Genetic modification of stem cells for transplantation
M. Ian Phillips et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Neural stem cells improve learning and memory in rats with Alzheimer's disease
Shuliang Wu et al.
PATHOBIOLOGY (2008)
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
MH Tuszynski et al.
NATURE MEDICINE (2005)
The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs
JM Burns et al.
NEUROLOGY (2005)
分享论文
